A team of researchers has uncovered the structure of a T-box regulatory mechanism in bacteria, which could aid in the development of novel antibiotics.
List view / Grid view
Filter the results
Antibiotics are a type of antimicrobial drug used in the treatment and prevention of bacterial infections.
A study has revealed an enzyme in bacteria that produces a molecule which is toxic to other bacteria and shows promise as an antibiotic substitute.
A new family of synthetic antibiotics that possess broad anti-Gram-negative antimicrobial activity has been discovered.
Glycans, which are found in mucus, have the ability to regulate how microbes behave and could lead to new therapeutics.
A technique to 'trick' bacteria into revealing pores in their cell walls has been developed and targeting these could make antibiotics more effective.
New antibiotics could be designed by discovering the mechanism a weapon bacteria uses to vanquish their competitors.
Researchers have used a high-throughput screening method to test over 125,000 molecules and identify a new class of antibiotics.
It is predicted that there will be 70 new monoclonal antibody (mAb) biotherapeutics available by 2020.
A new study has demonstrated the possibility of treating antibiotic-resistant Pseudomonas aeruginosa which causes sepsis in burn patients.
Scientists have shown that drug-resistant bacteria infections shut out antibiotics by closing tiny doors in their cell walls.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
Researchers have used a new method to understand how antibiotics fight TB, which can guide future drug developments.
Application note: Detection of anti-drug antibody (ADA) using single molecule counting (SMCTM) technology
All biological therapeutics have the potential to induce an immunemediated response ranging from benign to severe adverse effects.
The advent of immune checkpoint inhibitors is a major breakthrough in cancer immunotherapy...